LVTX NASDAQ
LAVA Therapeutics N.V.
1W: +0.0%
1M: +8.1%
3M: +10.8%
1Y: +8.1%
3Y: -69.5%
$1.74
Last traded 2025-11-28 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$20M
+49.9% ▲
Capital Expenditures
$23K
+96.9% ▲
5Y CAGR: -50.3%
Free Cash Flow
-$20M
+52.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$9M
+83.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$16M | -$42M | -$32M | -$42M | -$25M |
| Depreciation & Amort. | $464K | $558K | $781K | $612K | $467K |
| Stock-Based Comp. | $557K | $0 | $0 | $5M | $3M |
| Change in Working Capital | $5M | $11M | $34M | -$4M | $4M |
| Other Non-Cash Items | $869K | $2M | $1M | -$187K | -$2M |
| Operating Cash Flow | -$9M | -$29M | $4M | -$40M | -$20M |
| — Investing Activities — | |||||
| Capital Expenditures | -$502K | -$764K | -$587K | -$731K | -$23K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $88K |
| Investment Purchases | $0 | -$45M | -$71M | -$90M | -$97M |
| Investment Sales | $0 | $3M | $81M | $73M | $110M |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$502K | -$44M | $9M | -$18M | $12M |
| — Financing Activities — | |||||
| Net Debt Issuance | $2M | $680K | $611K | $0 | -$596K |
| Stock Repurchased | -$5M | -$5M | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$340K | -$343K | $0 | $0 |
| Financing Cash Flow | $19M | $151M | $283K | $0 | -$569K |
| Net Change in Cash | $8M | $75M | $9M | -$56M | -$9M |
| Cash End of Period | $16M | $91M | $100M | $44M | $35M |
| Free Cash Flow | -$10M | -$29M | $3M | -$41M | -$20M |